Claudia De Lorenzo - Concepedia

Author

Claudia De Lorenzo

Also Known As

C De Lorenzo, C Lorenzo, C. De Lorenzo, C. LORENZO, Carriera Lorenzo, Cipriano Lorenzo, Claudia De Lorenzo, Claudia Lorenzo, Claudia de Lorenzo, Covadonga Lorenzo

136

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Naples Federico II Ceinge Biotecnologie Avanzate (Italy)Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Federico II University Hospital Institute for Experimental Endocrinology and Oncology

About

Claudia De Lorenzo is an author at University of Naples Federico II specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	847
2	Cell Biology	13	16	556
3	Allergy	2	2	67
4	Engineering	1	1	17
5	Natural Sciences	1	1	66

Claudia De Lorenzo

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A Study of the Intracellular Routing of Cytotoxic Ribonucleases You-Neng Wu, Shailendra K. Saxena, Wojciech Ardelt, Journal of Biological Chemistry	1995	96
Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction Carlo G. Tocchetti, Andrea Carpi, Carmela Coppola, European Journal of Heart Failure	2014	88
The antitumor action of seminal ribonuclease and its quaternary conformations Valeria Cafaro, Claudia De Lorenzo, R Piccoli, FEBS Letters	1995	76
Fibrinogen Concentrate Reverses Dilutional Coagulopathy Induced In Vitro by Saline but Not by Hydroxyethyl Starch 6% Claudia De Lorenzo, Andreas Calatzis, Ulrich Welsch, Anesthesia & Analgesia	2006	75
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors Carmine Fedele, Gennaro Riccio, Angela Eliana Malara, Breast Cancer Research and Treatment CardiomyopathyMedicinePhysiologyCardiovascular PharmacologyPharmacotherapy	2012	72
Cardiotoxic effects, or lack thereof, of anti‐ErbB2 immunoagents Gennaro Riccio, Giovanni Esposito, Emanuela Leoncini, The FASEB Journal	2009	69
Human anti-nucleolin recombinant immunoagent for cancer therapy Dario Palmieri, Timothy Richmond, Claudia Piovan, Proceedings of the National Academy of Sciences Cancer TherapyTumor BiologySystems BiologyDrug TargetingMedicine	2015	67
A Fully Human Antitumor ImmunoRNase Selective for ErbB-2-Positive Carcinomas Claudia De Lorenzo, Angela Arciello, Rosanna Cozzolino, Cancer Research	2004	66
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane C Monaco, Roberta Visconti, Maria Vittoria Barone, Oncogene Signal TransductionSignaling PathwayPlasma MembraneCell RegulationCell Signaling	2001	66
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer Simona Camorani, Margherita Passariello, Lisa Agnello, Journal of Experimental & Clinical Cancer Research	2020	64

Page 1